compareglp-1

A comparison studio
Independent editorial information · not individual medical advice

Commercial pages may contain paid referral links. Compare the full payment terms and licensed-care details before enrollment.

Head-to-Head

Semaglutide vs. Tirzepatide in 2026: The Rematch With New Prices and New Evidence

The old answer was 'tirzepatide loses more weight, semaglutide has the outcomes data.' Both halves picked up new evidence — and new price tags.

Semaglutide versus tirzepatide is the foundational comparison of this entire drug class, and 2026 gave it a genuine update: direct head-to-head trial data, most-favored-nation pricing that changed the cost gap, and expanded indications on both sides. Here's the current state of the rematch.

The rematch, August 2026
Semaglutide (Wegovy/Ozempic)Tirzepatide (Zepbound/Mounjaro)
MechanismGLP-1 receptor agonistDual GIP + GLP-1 agonist
Avg. weight loss~15% (STEP 1)~22.5% top dose (SURMOUNT-1)
Head-to-headSURMOUNT-5: tirzepatide produced ~47% greater relative loss vs. semaglutide—
Outcomes evidenceSELECT: 20% MACE reduction, mortality benefit; kidney (FLOW), liver indicationsSleep apnea indication; heart-failure (HFpEF) data; outcomes program maturing
Cash price (MFN era)$199/mo pen · oral from $149$299/mo pen · vials $349–$449
FormatsWeekly pen, daily pillWeekly pen, vials

What's Genuinely New

Who Each Molecule Fits in 2026

Tirzepatide for maximum weight loss, higher starting BMIs, prior semaglutide plateaus, and comorbid sleep apnea. Semaglutide for documented cardiovascular/kidney/liver protection priorities, pill preference (tirzepatide has no oral), tighter budgets, and anyone whose target is well-served by ~15% average loss.

Brand-Name Route

Sesame Care

Brand-name route — Rybelsus, oral Wegovy, and injectable brand GLP-1s via low-cost doctor visits.

Flat-rate visits · brand-name FDA-approved medications only

  • FDA-approved brand-name medications only
  • Fast video visits in most states
  • Pairs well with $199 direct-pay channels
Visit Sesame Care

The Compounded Versions of This Matchup

The same comparison plays out in the compounded market at lower prices — with flat-rate programs removing tirzepatide's dose-price ladder:

SPONSORED CARE OPTION

Sesame

Compare treatment availability, consultation and membership charges, pharmacy fees and refill policies. Eligibility and medication choice are determined by a clinician.

Pricing, medication access, service area and plan terms must be confirmed with the provider. This is not a drug-specific checkout link.

Explore Sesame program ↗
Sema $99 · Tirz $133

GobyMeds

The lowest injectable price point we currently track.

Injectable compounded semaglutide $99/mo · tirzepatide $133/mo

  • Among the lowest injectable prices tracked
  • Direct pharmacy model
  • Flat monthly pricing

Compounded medications are not FDA-approved. They are prepared by licensed pharmacies but have not been evaluated by the FDA for safety, effectiveness, or quality.

Visit GobyMeds
Our verdict: tirzepatide is confirmed the efficacy champion; semaglutide is confirmed the evidence champion — and now everyone can actually afford to have the debate. If pounds-lost is the goal, tirzepatide. If organ-protection outcomes, oral format, or budget lead your criteria, semaglutide. There is no wrong answer here, only a wrong fit.

Bottom Line

2026 settled the old arguments and made both drugs accessible enough that the choice is finally clinical rather than financial. Bring your priorities — not just your goal weight — to the prescriber conversation.

Last updated August 2026. Trial figures are program averages; individual results vary. Discuss selection with a licensed provider.

See the Full Comparison Grid

Every provider and channel we track — price, format, and what's included — side by side.

Compare All Providers

More Comparisons

Orforglipron vs. Injectable Semaglutide

Zepbound Pen vs. Vial: The Price Ladder

Best Programs for Higher Doses: Flat-Rate Rankings

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. All prescription medications discussed require evaluation by a licensed healthcare provider. Always consult your doctor before starting, stopping, or changing any medication. Individual results vary.

Affiliate Disclosure: CompareGLP-1 may earn a commission when you use links on this page, at no additional cost to you. Links marked "Paid link" are sponsored. Our comparisons are editorially independent — rankings and verdicts are never sold, and we never fabricate statistics, testimonials, or reviews.